In addition, within the subgroup of melanoma patients harboring TERT promoter mutation, no statistically significant difference in disease-free survival was found between carriers and noncarriers of the rs2853669 −245A > G polymorphism (P = 0.92; Supplementary Table 1). This evidence concerns the gene TERT and melanoma.